These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23015402)

  • 1. Thymidylate synthase expression and prognosis in colorectal cancer: a meta-analysis of colorectal cancer survival data.
    Chen Y; Yi C; Liu L; Li B; Wang Y; Wang X
    Int J Biol Markers; 2012 Oct; 27(3):e203-11. PubMed ID: 23015402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis.
    Popat S; Matakidou A; Houlston RS
    J Clin Oncol; 2004 Feb; 22(3):529-36. PubMed ID: 14752076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy.
    Edler D; Glimelius B; Hallström M; Jakobsen A; Johnston PG; Magnusson I; Ragnhammar P; Blomgren H
    J Clin Oncol; 2002 Apr; 20(7):1721-8. PubMed ID: 11919227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of thymidylate synthase and dihydropyrimidine dehydrogenase in colorectal cancer of 303 patients adjuvantly treated with 5-fluorouracil.
    Jensen SA; Vainer B; Sørensen JB
    Int J Cancer; 2007 Feb; 120(3):694-701. PubMed ID: 17096352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and predictive value of thymidylate synthase expression in primary colorectal cancer.
    Karlberg M; Ohrling K; Edler D; Hallström M; Ullén H; Ragnhammar P
    Anticancer Res; 2010 Feb; 30(2):645-51. PubMed ID: 20332484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy.
    Shirota Y; Stoehlmacher J; Brabender J; Xiong YP; Uetake H; Danenberg KD; Groshen S; Tsao-Wei DD; Danenberg PV; Lenz HJ
    J Clin Oncol; 2001 Dec; 19(23):4298-304. PubMed ID: 11731512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment.
    Dotor E; Cuatrecases M; Martínez-Iniesta M; Navarro M; Vilardell F; Guinó E; Pareja L; Figueras A; Molleví DG; Serrano T; de Oca J; Peinado MA; Moreno V; Germà JR; Capellá G; Villanueva A
    J Clin Oncol; 2006 Apr; 24(10):1603-11. PubMed ID: 16575011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of thymidylate synthase expression in gastric cancer: a systematic review with meta-analysis.
    Hu HB; Kuang L; Zeng XM; Li B; Liu EY; Zhong MZ
    Asian Pac J Cancer Prev; 2012; 13(1):261-7. PubMed ID: 22502681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information.
    Ohrling K; Edler D; Hallström M; Ragnhammar P; Blomgren H
    J Clin Oncol; 2005 Aug; 23(24):5628-34. PubMed ID: 16009948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F1/TS Immunophenotype and Survival of Patients with Colorectal Cancer Treated with 5FU-Based Adjuvant Therapy.
    Sulzyc-Bielicka V; Domagala P; Bielicki D; Safranow K; Rogowski W; Domagala W
    Pathol Oncol Res; 2016 Jul; 22(3):601-8. PubMed ID: 26831819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
    Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, blinded analysis of thymidylate synthase and p53 expression as prognostic markers in the adjuvant treatment of colorectal cancer.
    Popat S; Chen Z; Zhao D; Pan H; Hearle N; Chandler I; Shao Y; Aherne W; Houlston R
    Ann Oncol; 2006 Dec; 17(12):1810-7. PubMed ID: 16971666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites.
    Johnston PG; Benson AB; Catalano P; Rao MS; O'Dwyer PJ; Allegra CJ
    J Clin Oncol; 2003 Mar; 21(5):815-9. PubMed ID: 12610179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of polymorphism of the tandem repeat sequence in the thymidylate synthase gene and the survival of stage III colorectal cancer patients receiving adjuvant 5-flurouracil-based chemotherapy.
    Park CM; Lee WY; Chun HK; Cho YB; Yun HR; Heo JS; Yun SH; Kim HC
    J Surg Oncol; 2010 Jan; 101(1):22-7. PubMed ID: 19798689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
    Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combined analysis of mismatch repair status and thymidylate synthase expression in stage II and III colon cancer.
    Öhrling K; Karlberg M; Edler D; Hallström M; Ragnhammar P
    Clin Colorectal Cancer; 2013 Jun; 12(2):128-35. PubMed ID: 23276521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidylate synthase (TS) protein expression as a prognostic factor in advanced colorectal cancer: a comparison with TS mRNA expression.
    Nakagawa T; Shimada M; Kurita N; Iwata T; Nishioka M; Yoshikawa K; Higashijima J; Utsunomiya T
    Hepatogastroenterology; 2012 Jun; 59(116):1059-62. PubMed ID: 22580655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer.
    Johnston PG; Fisher ER; Rockette HE; Fisher B; Wolmark N; Drake JC; Chabner BA; Allegra CJ
    J Clin Oncol; 1994 Dec; 12(12):2640-7. PubMed ID: 7989939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthase and cyclin D1 protein expression in lymph node negative colorectal cancer: role as prognostic factors?
    Formentini A; Henne-Bruns D; Kornmann M
    Hepatogastroenterology; 2012 Sep; 59(118):1859-64. PubMed ID: 22819905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.